Volcano Corp (NASDAQ:VOLC)

CAPS Rating: 2 out of 5

The Company is engages in the development, manufacture and commercialization of intravascular ultrasound and functional measurement products that are used for the diagnosis and treatment of vascular and structural heart disease.

Recs

1
Player Avatar OklaBoston (68.09) Submitted: 7/13/2009 2:22:48 PM : Underperform Start Price: $14.82 VOLC Score: +16.63

Another website tells me that this company's most recent earnings were less than concensus estimates, and that it's record on matching or beating estimates is unenviable.

Featured Broker Partners


Advertisement